Coronary Heart Disease
513
32
45
303
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
54 trials with published results (11%)
Research Maturity
303 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.1%
11 terminated out of 513 trials
96.5%
+9.9% vs benchmark
20%
103 trials in Phase 3/4
18%
54 of 303 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 303 completed trials
Clinical Trials (513)
Thiamine Intervention and Coronary Artery Bypass Grafting
Intranasal Dexmedetomidine and Perioperative Myocardial Injury
Impact of Cardiac Rehabilitation on Patient Outcomes
CHD Patient's Concern on Cardiac Rehabilitation
The Effect of Autonomic Neuropathy Status on the Endpoint Events in Diabetes Patients With Coronary Heart Disease and Sleep Apnea.
Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease
Family Heart Health Program: Randomized, Controlled Trial
Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation
Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)
Inclisiran Effectiveness in China: a Pragmatic Randomized Trial
Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease
Usability and Acceptability Study of the P-STEP Mobile Application
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
Mindfulness-based Stress Reduction Combined With Aerobic Training in Cardiac Rehabilitation After Percutaneous Coronary Intervention: A Dual Impact on Kinesiophobia and Heart Rate Variability
Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention
A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP
A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)